RU2008126209A - Дендример-пэг с четырьмя ветками для конъюгирования с белками и пептидами - Google Patents
Дендример-пэг с четырьмя ветками для конъюгирования с белками и пептидами Download PDFInfo
- Publication number
- RU2008126209A RU2008126209A RU2008126209/04A RU2008126209A RU2008126209A RU 2008126209 A RU2008126209 A RU 2008126209A RU 2008126209/04 A RU2008126209/04 A RU 2008126209/04A RU 2008126209 A RU2008126209 A RU 2008126209A RU 2008126209 A RU2008126209 A RU 2008126209A
- Authority
- RU
- Russia
- Prior art keywords
- group
- structure according
- conjugate
- polymer structure
- nucleophilic
- Prior art date
Links
- 0 CCCCC(*NC)N*OC Chemical compound CCCCC(*NC)N*OC 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/321—Polymers modified by chemical after-treatment with inorganic compounds
- C08G65/325—Polymers modified by chemical after-treatment with inorganic compounds containing nitrogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyethers (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Abstract
1. Полимерная дендример-подобная структура, включающая четыре ветви монометоксиполиэтиленгликоля, которая может быть представлена как: ! ! для получения конъюгатов, представляющих фармацевтический интерес. ! 2. Полимерная структура по п.1, где молекулярная масса каждой ПЭГ-цепи находится между 5000 и 30000 Д, а общая молекулярная масса находится между 20000 и 120000 Д. ! 3. Полимерная структура по п.2, активированная для конъюгирования с нуклеофильными группами, полученная функциональной активацией карбоксильной группы. ! 4. Конъюгат, включающий полимерную структуру по п.1 и нуклеофильную группу. ! 5. Конъюгат по п.4, где нуклеофильная группа содержится в биомолекуле, выбранной из группы, состоящей из белков, пептидов и полипептидов. ! 6. Конъюгат по п.5, где белок выбран из группы, состоящей из интерферона альфа 2-b, стрептокиназы, гранулоцитарного колониестимулирующего фактора, эритропоэтина и эпидермального ростового фактора.
Claims (6)
1. Полимерная дендример-подобная структура, включающая четыре ветви монометоксиполиэтиленгликоля, которая может быть представлена как:
для получения конъюгатов, представляющих фармацевтический интерес.
2. Полимерная структура по п.1, где молекулярная масса каждой ПЭГ-цепи находится между 5000 и 30000 Д, а общая молекулярная масса находится между 20000 и 120000 Д.
3. Полимерная структура по п.2, активированная для конъюгирования с нуклеофильными группами, полученная функциональной активацией карбоксильной группы.
4. Конъюгат, включающий полимерную структуру по п.1 и нуклеофильную группу.
5. Конъюгат по п.4, где нуклеофильная группа содержится в биомолекуле, выбранной из группы, состоящей из белков, пептидов и полипептидов.
6. Конъюгат по п.5, где белок выбран из группы, состоящей из интерферона альфа 2-b, стрептокиназы, гранулоцитарного колониестимулирующего фактора, эритропоэтина и эпидермального ростового фактора.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU2005-0241 | 2005-11-30 | ||
| CU20050241A CU23556A1 (es) | 2005-11-30 | 2005-11-30 | Estructura polimérica semejante a dendrímero para la obtención de conjugados de interés farmacéutico |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2008126209A true RU2008126209A (ru) | 2010-01-10 |
| RU2409389C2 RU2409389C2 (ru) | 2011-01-20 |
Family
ID=37672068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008126209/05A RU2409389C2 (ru) | 2005-11-30 | 2006-11-20 | Дендример-пэг с четырьмя ветками для конъюгирования с белками и пептидами |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8703893B2 (ru) |
| EP (1) | EP1967212B1 (ru) |
| JP (1) | JP5123201B2 (ru) |
| KR (1) | KR101134983B1 (ru) |
| CN (2) | CN101389354A (ru) |
| AR (1) | AR058841A1 (ru) |
| AU (1) | AU2006319636B2 (ru) |
| BR (1) | BRPI0604313A (ru) |
| CA (1) | CA2631335C (ru) |
| CU (1) | CU23556A1 (ru) |
| EG (1) | EG26619A (ru) |
| MY (1) | MY150739A (ru) |
| RU (1) | RU2409389C2 (ru) |
| UA (1) | UA91575C2 (ru) |
| UY (1) | UY29981A1 (ru) |
| WO (1) | WO2007062610A2 (ru) |
| ZA (1) | ZA200804694B (ru) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2636599C (en) * | 2006-01-20 | 2014-07-15 | Starpharma Pty Limited | Modified macromolecule |
| US8252834B2 (en) * | 2008-03-12 | 2012-08-28 | The Regents Of The University Of Michigan | Dendrimer conjugates |
| WO2010039861A2 (en) | 2008-09-30 | 2010-04-08 | The Regents Of The University Of Michigan | Dendrimer conjugates |
| US9017644B2 (en) | 2008-11-07 | 2015-04-28 | The Regents Of The University Of Michigan | Methods of treating autoimmune disorders and/or inflammatory disorders |
| US20100158850A1 (en) * | 2008-12-23 | 2010-06-24 | The Regents Of The University Of Michigan | Dendrimer based modular platforms |
| WO2011059609A2 (en) * | 2009-10-13 | 2011-05-19 | The Regents Of The University Of Michigan | Dendrimer compositions and methods of synthesis |
| WO2011059586A2 (en) | 2009-10-30 | 2011-05-19 | The Regents Of The University Of Michigan | Multifunctional small molecules |
| WO2013085718A1 (en) | 2011-12-08 | 2013-06-13 | The Regents Of The University Of Michigan | Multifunctional small molecules |
| WO2013096388A1 (en) | 2011-12-21 | 2013-06-27 | The Regents Of The University Of California | Telodendrimers with enhanced drug delivery |
| US9642916B2 (en) | 2012-12-12 | 2017-05-09 | The Regents Of The University Of California | Porphyrin modified telodendrimers |
| MY186423A (en) * | 2013-03-05 | 2021-07-22 | Hanmi Pharm Ind Co Ltd | Improved preparation method for high-yield production of physiologically active polypeptide conjugate |
| EP2786766A1 (en) * | 2013-04-05 | 2014-10-08 | Ufpeptides S.r.l. | Supramolecular aggregates comprising maleimido cores |
| EP3013790A1 (en) | 2013-06-27 | 2016-05-04 | Mylan Laboratories Ltd. | Process for the preparation of nepafenac |
| CU20140003A7 (es) * | 2014-01-08 | 2015-08-27 | Ct De Inmunología Molecular Biofarmacuba | Conjugado que comprende eritropoyetina y una estructura polimérica ramificada |
| SI3183264T1 (sl) | 2014-08-19 | 2021-03-31 | Biogen Ma Inc. | Metoda pegilacije |
| US20160361426A1 (en) * | 2015-06-11 | 2016-12-15 | Prolong Pharmaceuticals, LLC | Pegylated granulocyte colony stimulating factor (gcsf) |
| EP3385383B1 (en) | 2015-12-04 | 2021-04-07 | Zenyaku Kogyo Co., Ltd. | Anti-il-17 aptamer having improved retention in blood |
| AU2017205273C1 (en) | 2016-01-08 | 2022-12-01 | Ascendis Pharma Growth Disorders A/S | Controlled-release CNP agonists with reduced side-effects |
| BR112018011008A2 (pt) | 2016-01-08 | 2018-12-04 | Ascendis Pharma Growth Disorders As | agonistas de cnp de liberação controlada com ligação a npr-c baixa |
| EP3400022A1 (en) | 2016-01-08 | 2018-11-14 | Ascendis Pharma Growth Disorders A/S | Controlled-release cnp agonists with low initial npr-b activity |
| WO2017118693A1 (en) * | 2016-01-08 | 2017-07-13 | Ascendis Pharma Growth Disorders A/S | Cnp prodrugs with large carrier moieties |
| WO2017118700A1 (en) | 2016-01-08 | 2017-07-13 | Ascendis Pharma Growth Disorders A/S | Controlled-release cnp agonists with increased nep stability |
| EP3400019B1 (en) | 2016-01-08 | 2022-09-28 | Ascendis Pharma Growth Disorders A/S | Cnp prodrugs with carrier attachment at the ring moiety |
| JP7102005B2 (ja) | 2016-09-15 | 2022-07-19 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 改善されたハイブリッドテロデンドリマー |
| KR102531327B1 (ko) | 2016-09-29 | 2023-05-11 | 아센디스 파마 그로우쓰 디스오더스 에이/에스 | 조절 방출 cnp 아고니스트를 사용한 병용 요법 |
| CN109134282B (zh) * | 2017-06-28 | 2021-03-16 | 北京键凯科技股份有限公司 | 一种树状多缩乙二醇衍生物及其制备方法和应用 |
| WO2019001473A1 (zh) * | 2017-06-28 | 2019-01-03 | 北京键凯科技股份有限公司 | 一种树状多缩乙二醇衍生物及其制备方法和应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4732863A (en) | 1984-12-31 | 1988-03-22 | University Of New Mexico | PEG-modified antibody with reduced affinity for cell surface Fc receptors |
| US5951974A (en) * | 1993-11-10 | 1999-09-14 | Enzon, Inc. | Interferon polymer conjugates |
| US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| US5985263A (en) * | 1997-12-19 | 1999-11-16 | Enzon, Inc. | Substantially pure histidine-linked protein polymer conjugates |
| JP5170931B2 (ja) | 2000-10-16 | 2013-03-27 | 中外製薬株式会社 | Ｐｅｇ修飾エリスロポエチン |
| JP4758608B2 (ja) * | 2001-11-07 | 2011-08-31 | ネクター セラピューティックス | 分枝ポリマーおよびそれらの結合体 |
| US7144978B2 (en) * | 2002-01-15 | 2006-12-05 | Pan Asia Bio Co., Ltd. | Multidrop tree branching functional polyethylene glycol, methods of preparing and using same |
| CN1176137C (zh) * | 2002-01-15 | 2004-11-17 | 泛亚生物技术有限公司 | 多臂树杈型功能化聚乙二醇制备方法及它在药物中的应用 |
| CN1569892A (zh) * | 2004-04-30 | 2005-01-26 | 新峰生物科技（上海）有限公司 | 多臂树杈型聚乙二醇与蛋白质或多肽的结合物及其制备方法 |
| ITMI20020951A1 (it) | 2002-05-06 | 2003-11-06 | Univ Degli Studi Trieste | Derivati multifunzionali del polietilenglicole loro preparazione ed impiego |
| CA2510040C (en) | 2003-05-23 | 2012-01-03 | Nektar Therapeutics Al, Corporation | Polymeric reagents and polymer-biomolecule conjugates comprising carbamate linkages |
| JP2007501811A (ja) * | 2003-08-08 | 2007-02-01 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用。 |
| CA2552892C (en) * | 2004-01-08 | 2014-08-05 | Neose Technologies, Inc. | O-linked glycosylation of peptides |
| EP1768700B1 (en) | 2004-07-16 | 2010-12-15 | Nektar Therapeutics | Conjugates comprising gm-csf and a polymer |
| EP1848461A2 (en) | 2005-02-16 | 2007-10-31 | Nektar Therapeutics Al, Corporation | Conjugates of an epo moiety and a polymer |
| AU2006215566A1 (en) * | 2005-02-16 | 2006-08-24 | Novo Nordisk A/S | Insulinotropic agents conjugated with structurally well defined branched polymers |
-
2005
- 2005-11-30 CU CU20050241A patent/CU23556A1/es active IP Right Grant
-
2006
- 2006-10-19 BR BRPI0604313-5A patent/BRPI0604313A/pt not_active Application Discontinuation
- 2006-11-20 US US12/095,335 patent/US8703893B2/en not_active Expired - Fee Related
- 2006-11-20 RU RU2008126209/05A patent/RU2409389C2/ru not_active IP Right Cessation
- 2006-11-20 WO PCT/CU2006/000014 patent/WO2007062610A2/es active Search and Examination
- 2006-11-20 MY MYPI20081872 patent/MY150739A/en unknown
- 2006-11-20 EP EP06817995.1A patent/EP1967212B1/en active Active
- 2006-11-20 CN CNA2006800491651A patent/CN101389354A/zh active Pending
- 2006-11-20 CA CA2631335A patent/CA2631335C/en not_active Expired - Fee Related
- 2006-11-20 KR KR1020087015901A patent/KR101134983B1/ko active IP Right Grant
- 2006-11-20 AU AU2006319636A patent/AU2006319636B2/en not_active Ceased
- 2006-11-20 UA UAA200808587A patent/UA91575C2/ru unknown
- 2006-11-20 JP JP2008542584A patent/JP5123201B2/ja not_active Expired - Fee Related
- 2006-11-20 CN CN201510340715.6A patent/CN104906594B/zh not_active Expired - Fee Related
- 2006-11-28 AR ARP060105233A patent/AR058841A1/es not_active Application Discontinuation
- 2006-11-30 UY UY29981A patent/UY29981A1/es not_active Application Discontinuation
-
2008
- 2008-05-29 ZA ZA200804694A patent/ZA200804694B/xx unknown
- 2008-06-01 EG EG2008060905A patent/EG26619A/en active
Also Published As
| Publication number | Publication date |
|---|---|
| AR058841A1 (es) | 2008-02-27 |
| WO2007062610A2 (es) | 2007-06-07 |
| EP1967212B1 (en) | 2016-09-21 |
| AU2006319636B2 (en) | 2012-10-18 |
| JP5123201B2 (ja) | 2013-01-23 |
| EP1967212A2 (en) | 2008-09-10 |
| CA2631335A1 (en) | 2007-06-07 |
| ZA200804694B (en) | 2009-03-25 |
| KR101134983B1 (ko) | 2012-04-09 |
| UA91575C2 (ru) | 2010-08-10 |
| UY29981A1 (es) | 2007-06-29 |
| BRPI0604313A (pt) | 2007-01-30 |
| US20090082537A1 (en) | 2009-03-26 |
| CA2631335C (en) | 2013-07-16 |
| CU23556A1 (es) | 2010-07-20 |
| CN101389354A (zh) | 2009-03-18 |
| AU2006319636A1 (en) | 2007-06-07 |
| US8703893B2 (en) | 2014-04-22 |
| EG26619A (en) | 2014-04-08 |
| MY150739A (en) | 2014-02-28 |
| KR20080072960A (ko) | 2008-08-07 |
| CN104906594A (zh) | 2015-09-16 |
| CN104906594B (zh) | 2016-12-28 |
| JP2009517414A (ja) | 2009-04-30 |
| RU2409389C2 (ru) | 2011-01-20 |
| WO2007062610A3 (es) | 2007-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008126209A (ru) | Дендример-пэг с четырьмя ветками для конъюгирования с белками и пептидами | |
| Zhang et al. | Dynamic covalent polymers for biomedical applications | |
| Hu et al. | Polysarcosine as an alternative to PEG for therapeutic protein conjugation | |
| Wurm et al. | Squaric acid mediated synthesis and biological activity of a library of linear and hyperbranched poly (glycerol)–protein conjugates | |
| Jäger et al. | Branched and linear poly (ethylene imine)-based conjugates: synthetic modification, characterization, and application | |
| CY1119292T1 (el) | Κατευθυνομενη απο θεση τροποποιηση toy fviii | |
| DE69831402D1 (de) | Nicht antigen wirkende verzweigte polymerkonjugate | |
| DE60321825D1 (de) | Maleinsäureamid polymerderivate und ihre biokonjugate | |
| FI101706B1 (fi) | Toiminnallinen rekombinoimalla valmistettu proteiinipolymeeri | |
| WO2005065239A8 (en) | Novel recombinant proteins with n-terminal free thiol | |
| DE602006017667D1 (de) | Cysteinhaltiges peptid-tag zur stellenspezifischen konjugation von proteinen | |
| WO2006004959A3 (en) | Pegylated interferon alpha-1b | |
| DK2351844T3 (da) | Præparater til forøgelse af transport- og antisense-effektivitet af nukleinsyreanalog i celler | |
| DE50006269D1 (de) | Kombinationen zur einführung von nucleinsäuren in zellen | |
| GEP20084486B (en) | Polymer conjugates of interferon-beta with enhanced biological potency | |
| ATE364654T1 (de) | Polyamideketten von genauer länge und deren konjugate mit proteinen | |
| EA201070548A1 (ru) | Производные кератина и способы их получения | |
| Pola et al. | Polymer therapeutics with a coiled coil motif targeted against murine BCL1 leukemia | |
| RU2007133094A (ru) | Способ получения полимерных конъюгатов | |
| WO2007010552A3 (en) | N- terminal peg conjugate of erythropoietin | |
| CN110418815A (zh) | 借助于含有硫酸化或磺化组分的水凝胶，用于区分螯合不同物质组的物质的方法和材料 | |
| CN101495536A (zh) | 位点特异性聚乙二醇化的方法 | |
| Yang et al. | Investigation of nonfouling polypeptides of poly (glutamic acid) with lysine side chains synthesized by EDC· HCl/HOBt chemistry | |
| Pasut et al. | Improvement of drug therapy by covalent PEG conjugation: an overview from a research laboratory | |
| Mbizana et al. | Synthesis and cell interaction of statistical l-arginine–glycine–l-aspartic acid terpolypeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20191121 |